Skip to main content
. 2017 Mar 15;2017(3):CD012599. doi: 10.1002/14651858.CD012599

Lam 2002.

Clinical features and settings Routine screening
Participants 16,237 participants undergoing NT and biochemical testing
Hong Kong ‐ multi‐centre study
1997 to 2000
Pregnant women
Mean maternal age 30.5 years (19% > 35 years)
10‐14 weeks and 15‐18 weeks' gestation
Study design Prospective cohort
Target condition and reference standard(s) Down's syndrome: 35 cases
Reference standards: women considered high risk offered CVS (0.7%) or amniocentesis (11.8%). Follow‐up to birth
Index and comparator tests Maternal age
First trimester NT (FMF methods)
Second trimester free ßhCG and AFP (methods not reported)
Follow‐up By review of hospital and laboratory records and by directly telephoning women. Participants who defaulted the second trimester serum tests (n = 1015) and those who miscarried after NT but before serum testing (n = 91) were excluded from the study. Outcome obtained in 15,253 patients (93.9%)
Aim of study To report data on participants undergoing both first and second trimester methods of screening to assess the relative efficacy of different methods of screening
Test characteristics  
Reference standard used  
Notes  
Table of Methodological Quality
Item Authors' judgement Description
Representative spectrum? 
 All tests Yes Routine screening of typical pregnant population
Acceptable reference standard? 
 All tests Yes Karyotyping or follow‐up to birth
Partial verification avoided? 
 All tests Unclear Unclear if all women received a reference standard
Differential verification avoided? 
 All tests No Choice of reference standard depended on index test results
Incorporation avoided? 
 All tests Yes Reference standard was independent of the index test
Reference standard results blinded? 
 All tests No Reference standard interpreted with knowledge of index test results
Index test results blinded? 
 All tests Yes Index test interpreted without knowledge of reference standard results
Relevant clinical information? 
 All tests Yes Information available as would be in standard clinical practice
Uninterpretable results reported? 
 All tests Yes NT successful in 99.8% of cases
Withdrawals explained? 
 All tests Yes Details given for patients excluded and those without follow‐up data